Iterum Therapeutics

-$0.0394 (-4.96%) As of 7:38 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ITRM and other ETFs, options, and stocks.

About ITRM

Iterum Therapeutics Plc operates as a pharmaceutical company, which engages in the development and commercialization of sulopenem to be potentially the first and only oral and intravenous (IV) branded penem available. The company was founded by Corey N.

CEO
Corey N. Fishman
Employees
7
Headquarters
Dublin, Dublin
Founded
2015

ITRM Key Statistics

Market Cap
298.89M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
19.19M
High Today
$0.79
Low Today
$0.7424
Open Price
$0.79
Volume
3.77M
52 Week High
$3.00
52 Week Low
$0.451

ITRM Earnings

-$1.59
-$1.06
-$0.53
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 17, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure